Navigation Links
Gallus Strengthens Biologics CMO Business with Acquisition of Laureate
Date:10/1/2013

St. Louis, Missouri (PRWEB) October 01, 2013

Gallus BioPharmaceuticals, LLC (Gallus), a leading biologics contract manufacturing organization (CMO), today announced its acquisition of Laureate Biopharmaceutical Services, Inc. (Laureate), a full service biologics CMO located in Princeton, New Jersey. This acquisition doubles Gallus’ process development (PD) and clinical drug substance manufacturing capacity, adds full protein characterization, testing and clinical fill-finish capability and offers a seamless development pathway for clients - from early stage PD and clinical manufacturing to commercial manufacturing.

United by a common mission to deliver outstanding clinical and commercial CMO services, the merged companies combine two organizations with proven track records and offer clients two Centers of Excellence for manufacturing therapeutic proteins using mammalian cell-culture: The Princeton site is a Center of Excellence for PD     solutions and manufacture of clinical-stage products, including fill-finish; the St. Louis site is a Center of Excellence for PD, clinical and commercial manufacture of biopharmaceutical products. Both sites are FDA approved, while the St. Louis site is also licensed by every major regulatory authority globally.

Gallus, a pure-play CMO, now has multiple clinical and commercial suites at the two sites, with 50L to 2,000L GMP single-use platforms from XcellerexTM and HyCloneTM in addition to 50L to 2,000L fixed and flexible stainless steel bioreactors and associated downstream purification for drug substance. Additionally, clinical fill-finish capabilities are part of the Princeton site. All of these services will be delivered by the combined team of 350 experienced and dedicated staff.

Michael A. Griffith, Laureate CEO, who will support the trans
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Gallus BioPharmaceuticals Enters Clinical Supply Agreement with Genzyme for Niemann-Pick Type B Disease
2. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer
3. inVentiv Health Clinical Expands and Strengthens Executive Team with Three Strategic Appointments
4. SentoClone International AB Significantly Strengthens its Global Patent Portfolio Covering its Clinical Stage Sentinel Node-derived CD4 T-cell Cancer Therapy
5. BellBrook Labs Strengthens Ties with Cambio for Distribution of Transcreener HTS Assays in the UK
6. Cytos Biotechnology Strengthens Management Team
7. Delta Point Strengthens Management and Expands Consultancy Services with Addition of Former AstraZeneca Executive Michael Hickey
8. Molecular Detection Inc. Further Strengthens Patent Portfolio Broadly Covering Detection of Antibiotic-Resistant Bacteria
9. AMRI Strengthens Business Development and Marketing Groups
10. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
11. CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... JUPITER, Fla. , Feb. 26, 2015 /PRNewswire/ ... biotechnology company whose patented and proprietary technologies are ... other proteins for the bioenergy, bio-based chemical, biopharmaceutical ... will report its financial results for year ending ... March 11, 2015 and will host a conference ...
(Date:2/26/2015)... Feb. 26, 2015 Ceres, Inc . ... in Oracle PartnerNetwork. In attaining Gold Level membership, Ceres ... establish Oracle-related knowledge in delivering Ceres, Persephone genome visualization ... customers. Originally developed for in-house use by ... in and out of massive amounts of genetic data, ...
(Date:2/26/2015)... DIEGO , Feb. 26, 2015  Epic Sciences ... , Ph.D. will present at the 35th Annual Cowen ... a.m. EST in the MIT Room, 3rd Floor. The ... Place Hotel in Boston, Mass. Epic is developing ... detection of genomic and proteomic changes that occur during ...
(Date:2/26/2015)... Feb. 26, 2015  Spark Therapeutics (NASDAQ: ONCE ... will participate in the Cowen and Company Health Care ... Eastern, at the Boston Marriott Copley Place. ... presentation from the Cowen conference, please visit the "Upcoming ... the Spark Therapeutics website at www.sparktx.com .  A ...
Breaking Biology Technology:Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3Ceres Becomes Oracle PartnerNetwork Gold Level Partner 2Ceres Becomes Oracle PartnerNetwork Gold Level Partner 3Ceres Becomes Oracle PartnerNetwork Gold Level Partner 4Epic Sciences to Present at 35th Annual Cowen and Company Health Care Conference 2Spark Therapeutics to Participate in the 35th Annual Cowen and Company Health Care Conference 2
... SAN FRANCISCO, Calif., April 8, 2008 Raven,biotechnologies, ... discovery,and development of monoclonal antibody therapeutics (MAbs) for ... agreement with Monogram,Biosciences, Inc., under which Monogram will ... VeraTag(TM) technology for diagnosis,of cancer., "Raven,s extensive ...
... Flexibility, Expanding Physicians ... the Treatment of Prostate Cancer, SUNNYVALE, Calif., April ... global leader in the field of radiosurgery,announced today that ... the,International Journal of Radiation Oncology*Biology*Physics -- also known,as the ...
... The Board of Molecular Vision today,announces that discussions ... have now ceased. Acrongenomics has been unable to,complete ... the Board of,Molecular Vision believes that the best ... discussions to a conclusion. Acrongenomics remains a,significant shareholder ...
Cached Biology Technology:Raven biotechnologies Announces Collaboration With Monogram Biosciences to Advance Diagnostic Cancer Technologies 2CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal 2CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal 3CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal 4
(Date:2/10/2015)...  Alere Inc. (NYSE: ALR), a global leader ... the quarter ended December 31, 2014. ... Alere said, "We made substantial progress in the ... leader in rapid diagnostics and delivering against our ... in early January enabled us to substantially reduce ...
(Date:2/5/2015)... PARK, North Carolina , 5. Februar ... 35. Jahr als spezialisiertes Logistikunternehmen und hat ... als einzige klinische Logistikfirma (Clinical Logistics Organization ... Kernbotschaft der neuen Kampagne lautet First ... Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... DIEGO , Jan. 26, 2015   Epic Sciences ... of cancer, today announced that Murali Prahalad , Ph.D., ... Personalized Medicine World Conference (PMWC) 2015: Silicon Valley, which ... Mountain View, Calif. on January 26-28, 2015. ... "CTCs Come of Age as Biomarkers." Last year, Epic Sciences ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... food choices based on television advertising results in a very ... content of food choices influenced by television to nutritional guidelines ... the American Dietetic Association . Investigators found that ... 25 times the recommended servings of sugars and 20 times ...
... have identified a previously unknown kinase that regulates cell proliferation, ... the progression or metastasis of cancer cells. The ... Edition of the Proceedings of the National Academy of ... at the UCSD School of Medicine and the Moores Cancer ...
... 31, 2010) -- A compound found in sunless tanning spray ... results published by plastic surgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical ... University in Ithaca, N.Y., where the novel compound was developed. ... National Academy of Sciences show that a sticky gel ...
Cached Biology News:TV food advertisements promote imbalanced diets 2Newly discovered kinase regulates cytoskeleton, and perhaps holds key to how cancer cells spread 2Sugary band-aid may help heal post-operative tissue 2
Fluorescein isothiocyanate (FITC) mouse anti-human IFN-alpha2 25 tests...
Dog polyclonal to Porcine Pancreatic Islets of Langerhans Cells ( Abpromise for all tested applications). Antigen: Tissue / cell preparation (Pig): Sonicated crude membrane fraction of porcine p...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Anti-Cohesin (Scc1/Rad21) Monoclonal Antibody Research Focus: signal transduction Storage: -20C Shipping Temperature: +4C...
Biology Products: